LDC’s pharmaceutical industry communications company Fishawack has bolted on US-based Carling Group.
LDC acquired Fishawack in a £38m (€43.0m) deal from Growth Capital Partners in January. This deal is the first acquisition in a planned buy-and-build strategy.
Based in Cheshire in the north of England, Fishawack provides marketing, consulting and medical writing services. It employs around 230 people at sites in the UK, the US, and Switzerland. Its clients include GSK, Novartis and Sanofi.
The Carling Group consists of Carling Communications, a healthcare marketing and communications agency, and MCME Global, a provider of medical education services. Both businesses are based in San Diego and the group also has a presence in London.
LDC was advised by BDO, KPMG, Candesic, Hill Dickinson, Foley & Lardener, and Addleshaw Goddard. Carling’s management was advised by Orrick.